XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2016   11,093,489      
Beginning balance at Dec. 31, 2016 $ 188,374 $ 111 $ 35,453 $ 152,810  
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]          
Stock-based compensation 11,627   11,627    
Issuance of restricted stock, net (in shares)   73,936      
Issuance of restricted stock, net 0 $ 1 (1)    
Common stock dividends (11,416)     (11,416)  
Net income (loss) 20,612     20,612  
Unrealized gains on marketable securities, net of tax 0        
Ending balance (in shares) at Dec. 31, 2017   11,167,425      
Ending balance at Dec. 31, 2017 209,197 $ 112 47,079 162,006  
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]          
Stock-based compensation 14,994   14,994    
Issuance of restricted stock, net (in shares)   155,874      
Issuance of restricted stock, net (776) $ 1 (777)    
Common stock dividends (27,842)     (27,842)  
Net income (loss) (15,671)     (15,671)  
Impact of adoption of new accounting standard | Accounting Standards Update 2014-09 (171)     (171)  
Issuance of stock in connection with the acquisition of Capella Education Company (in shares)   10,263,775      
Issuance of stock in connection with the acquisition of Capella Education Company 1,236,961 $ 103 1,236,858    
Filing fee related to new stock issuance (148)   (148)    
Exercise of stock options, net (in shares)   156,424      
Exercise of stock options, net 8,648 $ 1 8,647    
Unrealized gains on marketable securities, net of tax 32       $ 32
Ending balance (in shares) at Dec. 31, 2018   21,743,498      
Ending balance at Dec. 31, 2018 1,425,224 $ 217 1,306,653 118,322 32
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]          
Stock-based compensation 12,116   12,033 83  
Issuance of restricted stock, net (in shares)   117,947      
Issuance of restricted stock, net (7,472) $ 1 (7,473)    
Common stock dividends (46,724)     (46,724)  
Net income (loss) 81,138     81,138  
Exercise of stock options, net (in shares)   103,364      
Exercise of stock options, net (1,773) $ 2 (1,775)    
Unrealized gains on marketable securities, net of tax 201       201
Ending balance (in shares) at Dec. 31, 2019   21,964,809      
Ending balance at Dec. 31, 2019 $ 1,462,710 $ 220 $ 1,309,438 $ 152,819 $ 233